Alzheimer’s testing goes painless, homebound with Neurogen-Tasso partnership
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
A key highlight will be Brenntag’s qualified amino acids portfolio
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
Adzynma, approved for both adults and children with cTTP, is a recombinant enzyme therapy designed to replace the deficient ADAMTS13 enzyme
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
Paxton alleges the companies marketed Plavix as a reliable defense against heart attacks, strokes, and blood clots while failing to disclose evidence that the drug could be ineffective or virtually useless for many people
The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
The company will soon be launching a new portfolio of products in this segment
Subscribe To Our Newsletter & Stay Updated